TetraLogic Pharmaceuticals Corporation (NasdaqGM:TLOG) has filed a Shelf Registration in the amount of $150 million. The net proceeds will be used for general corporate purposes, including working capital, continued development of product candidate pipeline, acquisitions, retirement of debt and other business opportunities.